269
Views
6
CrossRef citations to date
0
Altmetric
Review Article

An overview on the methods of determining the activity of Indoleamine 2, 3-Dioxygenase 1

, , , &
Pages 724-731 | Received 10 Jul 2018, Accepted 05 Sep 2018, Published online: 05 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ilona Sadok, Kamila Rachwał, Ilona Jonik & Magdalena Staniszewska. (2021) Reliable chromatographic assay for measuring of indoleamine 2,3-dioxygenase 1 (IDO1) activity in human cancer cells. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 581-592.
Read now

Articles from other publishers (5)

Haiyan Zhang, Jing Li & Qi Zhou. (2022) Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis. Frontiers in Oncology 12.
Crossref
Zhuoting Liu, Chunling Wang, Xu Wang & Ann Van Schepdael. (2021) On-line screening of indoleamine 2,3-dioxygenase 1 inhibitors by partial filling capillary electrophoresis combined with rapid polarity switching. Journal of Chromatography A 1651, pages 462305.
Crossref
Ana Dolšak, Stanislav Gobec & Matej Sova. (2021) Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets. Pharmacology & Therapeutics 221, pages 107746.
Crossref
Huizhen Ge, Longfei Mao, Jie Zhao, Yuwei Wang, Danfeng Shi, Xing Yang, Xiaorui Wang, Huanxiang Liu & Xiaojun Yao. (2021) Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays. Journal of Computer-Aided Molecular Design 35:5, pages 679-694.
Crossref
Fangfang Jin, Qiyue Hu, Hongbo Fei, Hejun Lv, Shenglan Wang, Bin Gui, Junzhen Zhang, Wangyang Tu, Yun Zhang, Lei Zhang, Hong Wan, Limin Zhang, Bin Hu, Fanglong Yang, Chang Bai, Feng He, Lianshan Zhang & Weikang Tao. (2021) Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors. ACS Medicinal Chemistry Letters 12:2, pages 195-201.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.